Annie Nguyentat, DPM
Podiatry · Roseville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Roseville Orthopedic Group A Medical Corp · 4 clinicians in this group
Hospitals listed: Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Nguyentat’s office at (916) 782-1217 to ask if they take your plan before you enroll.
California Medical Board record
Surgery centers they own
- South Placer Surgery Center LP dba Sutter Sierra Surgery CenterAmbulatory Surgery Center · Roseville, CA1.01% owner since 2021 · accredited by AAAHCAccreditation Renewed5 inspections, 2 with deficiencies · last 2024-01-22
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$76,499
Medicare paid this office $76,499 for 221 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 104 | $16,053 | $71 |
| Long return visit (40+ min) | 87 | $14,886 | $139 |
| New patient visit (45+ min) | 86 | $10,496 | $122 |
| Return visit (30+ min) | 69 | $9,291 | $98 |
| Removal of noncancer thickened skin growth, 2-4 growths | 20 | $2,216 | $55 |
See all 10 services
| Short return visit (20+ min) | 104 | $16,053 | $71 |
| Long return visit (40+ min) | 87 | $14,886 | $139 |
| New patient visit (45+ min) | 86 | $10,496 | $122 |
| Return visit (30+ min) | 69 | $9,291 | $98 |
| Removal of noncancer thickened skin growth, 2-4 growths | 20 | $2,216 | $55 |
| Removal of noncancer thickened skin growth, 1 growth | 24 | $1,943 | $57 |
| Aspiration and/or injection of fluid from medium joint | 16 | $1,093 | $48 |
| Short return visit | 13 | $498 | $38 |
| Placement of strapping to toes | 11 | $148 | $12 |
| Injection, methylprednisolone acetate, 1 mg | 23 | $99 | None |
Procedures Medicare counted
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 14 | More than 60% of doctors who do this |
| Removal of skin lesions | 1-10 | None |
| Removal of tissue | 12 | More than 63% of doctors who do this |
| Removal or shaving of skin growth | 141 | More than 87% of doctors who do this |
Who their Medicare patients are
221 Original Medicare patients in 2024. Average age 75 · Women 68% · Health risk score 0.96. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 71% · Coronary heart disease 21% · Depression 21% · Chronic kidney disease 20% · Diabetes 19% · Cancer 19% · Atrial fibrillation 17% · COPD 12% · Heart failure 9% · Stroke 7%.
The office billed $238,564, Medicare allowed $103,442 and paid $76,499; for 1,810 services of 57 kinds; $142 of it was for drugs given in the office and $76,357 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 221 | 1,810 | 75 | 0.96 | $238,564 | $76,499 |
| 2023 | 212 | 956 | 75 | 1.05 | $290,154 | $74,867 |
| 2022 | 218 | 1,105 | 74 | 0.85 | $215,370 | $73,463 |
| 2021 | 223 | 1,000 | 74 | 0.90 | $221,742 | $74,991 |
| 2020 | 241 | 1,165 | 74 | 0.96 | $307,452 | $74,709 |
| 2019 | 288 | 1,478 | 74 | 0.91 | $363,305 | $91,745 |
| 2018 | 297 | 1,769 | 74 | 1.02 | $526,566 | $115,896 |
| 2017 | 405 | 2,576 | 74 | 1.06 | $500,043 | $170,530 |
| 2016 | 395 | 2,263 | 73 | 1.04 | $432,871 | $151,162 |
| 2015 | 189 | 785 | 73 | 1.68 | $128,389 | $42,885 |
| 2014 | 56 | 112 | 73 | 1.16 | $35,493 | $8,547 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Short return visit (20+ min) | 98 | $13,398 | $72 |
| New patient visit (45+ min) | 106 | $13,356 | $126 |
| Long return visit (40+ min) | 56 | $9,232 | $142 |
| Return visit (30+ min) | 67 | $7,857 | $101 |
| Removal of noncancer thickened skin growth, 2-4 growths | 23 | $3,836 | $70 |
| X-ray of foot, minimum of 3 views | 49 | $2,180 | $30 |
| Removal of noncancer thickened skin growth, 1 growth | 20 | $1,825 | $54 |
| Biopsy of fingernail or toenail | 12 | $1,342 | $103 |
| X-ray of ankle, minimum of 3 views | 23 | $1,059 | $33 |
| Short return visit | 21 | $1,029 | $43 |
| Aspiration and/or injection of fluid from medium joint | 13 | $920 | $46 |
| Placement of strapping to toes | 22 | $317 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 23 | $167 | None |
2022: 16 services
| New patient visit (45+ min) | 90 | $11,455 | $127 |
| Short return visit (20+ min) | 78 | $10,774 | $71 |
| Long return visit (40+ min) | 58 | $10,062 | $146 |
| Return visit (30+ min) | 49 | $6,917 | $103 |
| X-ray of foot, minimum of 3 views | 94 | $3,996 | $29 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 12 | $3,636 | $63 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $2,591 | $68 |
| X-ray of ankle, minimum of 3 views | 39 | $1,889 | $33 |
| New patient visit (30+ min) | 14 | $1,324 | $95 |
| Removal of noncancer thickened skin growth, 1 growth | 12 | $961 | $53 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 20 | $928 | $16 |
| Aspiration and/or injection of fluid from medium joint | 13 | $883 | $42 |
| Therapy procedure using manual technique, each 15 minutes | 19 | $358 | $14 |
| Placement of strapping to toes | 21 | $317 | $15 |
| Injection, methylprednisolone acetate, 40 mg | 17 | $123 | None |
| Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 16 | $122 | $6 |
2021: 17 services
| Short return visit (20+ min) | 105 | $14,085 | $73 |
| New patient visit (45+ min) | 74 | $9,568 | $129 |
| Return visit (30+ min) | 59 | $8,041 | $106 |
| Long return visit (40+ min) | 47 | $7,662 | $147 |
| X-ray of foot, minimum of 3 views | 55 | $2,356 | $29 |
| New patient visit (30+ min) | 26 | $2,084 | $80 |
| New patient visit (60+ min) | 11 | $1,964 | $179 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 21 | $1,420 | $22 |
| Removal of noncancer thickened skin growth, 2-4 growths | 15 | $1,410 | $64 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $1,230 | $56 |
| X-ray of ankle, minimum of 3 views | 21 | $868 | $30 |
| Short return visit | 14 | $789 | $38 |
| Aspiration and/or injection of fluid from small joint | 11 | $590 | $42 |
| Therapy procedure using manual technique, each 15 minutes | 17 | $493 | $18 |
| Placement of strapping to toes | 23 | $267 | $12 |
| Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 15 | $175 | $8 |
| Injection, methylprednisolone acetate, 40 mg | 19 | $115 | None |
2020: 13 services
| Short return visit (20+ min) | 122 | $14,532 | $59 |
| New patient visit (30+ min) | 115 | $9,824 | $85 |
| Return visit (30+ min) | 84 | $8,485 | $84 |
| X-ray of foot, minimum of 3 views | 106 | $4,660 | $27 |
| New patient visit (45+ min) | 18 | $2,445 | $136 |
| X-ray of ankle, minimum of 3 views | 50 | $1,961 | $29 |
| Removal of noncancer thickened skin growth, 1 growth | 20 | $1,190 | $46 |
| X-ray of foot, 2 views | 31 | $939 | $24 |
| Removal of noncancer thickened skin growth, 2-4 growths | 12 | $679 | $57 |
| Placement of strapping to toes | 28 | $376 | $13 |
| Short return visit | 11 | $307 | $28 |
| Injection, methylprednisolone acetate, 40 mg | 20 | $121 | None |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $91 | $8 |
2019: 16 services
| Short return visit (20+ min) | 132 | $14,696 | $59 |
| Return visit (30+ min) | 111 | $11,552 | $85 |
| New patient visit (30+ min) | 134 | $11,214 | $84 |
| X-ray of ankle, minimum of 3 views | 118 | $4,957 | $27 |
| X-ray of foot, minimum of 3 views | 111 | $4,942 | $26 |
| New patient visit (45+ min) | 22 | $2,756 | $125 |
| X-ray of foot, 2 views | 91 | $2,564 | $22 |
| Removal of noncancer thickened skin growth, 1 growth | 20 | $907 | $38 |
| Application of walking cast covering below knee to toe | 12 | $827 | $59 |
| Removal of noncancer thickened skin growth, 2-4 growths | 13 | $761 | $51 |
| Aspiration and/or injection of fluid from large joint | 11 | $673 | $45 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 15 | $665 | $33 |
| Injection into tendon or ligament | 11 | $469 | $36 |
| Placement of strapping to toes | 27 | $414 | $13 |
| Application of short leg splint from calf to foot | 12 | $272 | $21 |
| Injection, methylprednisolone acetate, 40 mg | 30 | $169 | None |
2018: 26 services
| Short return visit (20+ min) | 152 | $15,624 | $56 |
| Return visit (30+ min) | 106 | $12,682 | $83 |
| New patient visit (30+ min) | 118 | $9,868 | $84 |
| X-ray of ankle, minimum of 3 views | 117 | $5,271 | $26 |
| New patient visit (45+ min) | 34 | $4,537 | $133 |
| X-ray of foot, minimum of 3 views | 85 | $3,479 | $24 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 11 | $3,275 | $298 |
| X-ray of foot, 2 views | 97 | $3,007 | $22 |
| Long return visit (40+ min) | 23 | $2,550 | $106 |
| Muscle electrical test | 11 | $1,613 | $147 |
| Removal of noncancer thickened skin growth, 1 growth | 33 | $1,377 | $35 |
| Simple separation of fingernail or toenail from nail bed, first nail | 14 | $1,350 | $84 |
| Testing of nerve-muscle junction | 12 | $1,255 | $70 |
| Application of walking cast covering below knee to toe | 15 | $1,250 | $66 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 12 | $1,218 | $76 |
| Aspiration and/or injection of fluid from large joint | 19 | $1,107 | $46 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 14 | $998 | $26 |
| Muscle electrical test | 12 | $980 | $82 |
| Removal of noncancer thickened skin growth, 2-4 growths | 20 | $973 | $44 |
| Application of short leg splint from calf to foot | 13 | $908 | $57 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 19 | $780 | $32 |
| Injection into tendon or ligament | 16 | $699 | $39 |
| Placement of strapping to toes | 37 | $443 | $12 |
| Application of short leg splint from calf to foot | 19 | $413 | $21 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $232 | None |
| Cast supplies, short leg splint, adult (11 years +), plaster | 11 | $110 | $9 |
2017: 24 services
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 98 | $28,906 | $286 |
| Short return visit (20+ min) | 166 | $17,488 | $55 |
| Muscle electrical test | 91 | $13,922 | $142 |
| Return visit (30+ min) | 105 | $11,121 | $81 |
| New patient visit (30+ min) | 138 | $10,637 | $77 |
| Testing of nerve-muscle junction | 99 | $10,528 | $67 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 107 | $9,900 | $26 |
| Muscle electrical test | 98 | $8,107 | $76 |
| X-ray of ankle, minimum of 3 views | 176 | $6,115 | $24 |
| New patient visit (45+ min) | 41 | $5,064 | $124 |
| Placement of skin electrodes and measurement of central motor stimulation in arms and legs | 11 | $4,269 | $388 |
| X-ray of foot, 2 views | 168 | $4,079 | $20 |
| X-ray of foot, minimum of 3 views | 54 | $2,155 | $22 |
| Long return visit (40+ min) | 19 | $2,093 | $110 |
| Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less | 17 | $1,916 | $71 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,550 | $43 |
| Removal of noncancer thickened skin growth, 2-4 growths | 20 | $1,247 | $42 |
| Application of short leg cast | 16 | $1,121 | $62 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $965 | $28 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 21 | $852 | $29 |
| Injection into tendon or ligament | 15 | $699 | $39 |
| X-ray of heel, minimum of 2 views | 21 | $553 | $21 |
| Placement of strapping to toes | 36 | $454 | $12 |
| Injection, methylprednisolone acetate, 40 mg | 46 | $243 | None |
2016: 20 services
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 75 | $22,454 | $288 |
| Short return visit (20+ min) | 137 | $15,562 | $57 |
| New patient visit (30+ min) | 165 | $13,375 | $81 |
| Muscle electrical test | 75 | $10,984 | $141 |
| Testing of nerve-muscle junction | 80 | $8,144 | $68 |
| Return visit (30+ min) | 73 | $7,936 | $87 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 90 | $7,879 | $26 |
| Muscle electrical test | 80 | $6,559 | $78 |
| X-ray of foot, minimum of 3 views | 145 | $4,169 | $23 |
| New patient visit (45+ min) | 28 | $3,565 | $127 |
| X-ray of ankle, 2 views | 122 | $3,226 | $24 |
| Replacement of knee joint, both sides of knee | 14 | $2,528 | $169 |
| X-ray of ankle, minimum of 3 views | 73 | $2,490 | $26 |
| Aspiration and/or injection of fluid from large joint | 27 | $1,578 | $49 |
| X-ray of foot, 2 views | 57 | $1,345 | $22 |
| Removal of noncancer thickened skin growth, 1 growth | 27 | $1,118 | $37 |
| Removal of noncancer thickened skin growth, 2-4 growths | 13 | $682 | $49 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 12 | $606 | $32 |
| Placement of strapping to toes | 14 | $189 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 40 | $178 | None |
2015: 10 services
| Short return visit (20+ min) | 55 | $4,927 | $62 |
| New patient visit (30+ min) | 49 | $4,386 | $90 |
| Return visit (30+ min) | 36 | $3,566 | $87 |
| Muscle electrical test | 23 | $3,340 | $145 |
| Testing of nerve-muscle junction | 26 | $2,656 | $70 |
| Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure) | 26 | $2,180 | $26 |
| Muscle electrical test | 26 | $1,954 | $75 |
| X-ray of foot, minimum of 3 views | 37 | $1,017 | $24 |
| Removal of fingernails or toenails, 6 or more nails | 20 | $951 | $40 |
| X-ray of ankle, 2 views | 18 | $431 | $23 |
2014: 1 service
| Short return visit (20+ min) | 16 | $1,567 | $68 |
Drugs they prescribed that Part D paid
$528
Pharmacies billed $528 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 40% of their Part D prescriptions (21 of 52) in 2024. A higher opioid share than 9 in 10 peers; the typical podiatry clinician is at 5%.
52 generic and 0 brand-name prescriptions · $528 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 18 | $96 | $5 |
Year by year
| 2024 | 52 | 23 | 40% (21) | 0% | $528 |
| 2023 | 61 | 27 | 21% (13) | None | $4,411 |
| 2022 | 64 | 25 | 22% (14) | None | $1,446 |
| 2021 | 77 | 32 | 25% (19) | None | $3,040 |
| 2020 | 82 | 37 | 22% (18) | None | $1,571 |
| 2019 | 85 | 38 | 33% (28) | None | $1,120 |
| 2018 | 109 | 45 | 41% (45) | None | $1,411 |
| 2017 | 86 | 36 | 41% (35) | None | $1,349 |
| 2016 | 74 | 23 | 43% (32) | None | $756 |
| 2015 | 27 | 22 | 56% (15) | 0% | $1,158 |
| 2014 | 24 | 11 | 46% (11) | 0% | $813 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Gabapentin | 13 | $268 | $21 |
2022: 1 drug
| Gabapentin | 21 | $222 | $11 |
2021: 3 drugs
| Gabapentin | 21 | $224 | $11 |
| Hydrocodone-Acetaminophen | 12 | $150 | $12 |
| Ondansetron Odt | 13 | $93 | $7 |
2020: 1 drug
| Gabapentin | 24 | $220 | $9 |
2019: 2 drugs
| Gabapentin | 24 | $277 | $12 |
| Hydrocodone-Acetaminophen | 22 | $263 | $12 |
2018: 3 drugs
| Hydrocodone-Acetaminophen | 39 | $676 | $17 |
| Ondansetron Odt | 12 | $103 | $9 |
| Gabapentin | 12 | $70 | $6 |
2017: 2 drugs
| Hydrocodone-Acetaminophen | 18 | $184 | $10 |
| Ondansetron Odt | 13 | $85 | $7 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 20 | $293 | $15 |
Money from drug and device companies
$502 in 2025
| 2025 | 5 | 6 | None | $502 |
| 2024 | 2 | 2 | None | $165 |
| 2023 | 2 | 3 | None | $146 |
| 2022 | 4 | 29 | None | $7,141 |
| 2021 | 7 | 10 | None | $1,744 |
| 2020 | 2 | 3 | None | $930 |
| 2019 | 7 | 25 | None | $5,398 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| DePuy Synthes Sales | Motoband | $148 | 1 payment
|
| Stryker | Augment Injectable | $140 | 2 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $101 | 1 payment
|
| Paragon 28 | Silverback | $80 | 1 payment
|
| Evolution Surgical | None | $34 | 1 payment
|
See all 6 published payments
| Evolution Surgical | Meals · 2025-09-10 | None | $34 |
| DePuy Synthes Sales | Meals · 2025-08-20 | Motoband | $148 |
| Bioventus | Meals · 2025-08-20 | Exogen Ultrasound Bone Healing System | $101 |
| Paragon 28 | Meals · 2025-03-29 | Silverback | $80 |
| Stryker | Meals · 2025-03-28 | Prostep Mica | $19 |
| Stryker | Meals · 2025-03-28 | Augment Injectable | $121 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $165
| Bone Support | Ceramentbone Void Filler | $146 | 1 payment
|
| Evolution Surgical | None | $18 | 1 payment
|
2023: $146
| DePuy Synthes Sales | Na | $104 | 2 payments
|
| Globus Medical | Ankle Fracture System | $41 | 1 payment
|
2022: $7,141
| Arthrex | None | $4,785 | 20 payments
|
| Evolution Surgical | None | $2,141 | 5 payments
|
| Bioventus | Exogen Ultrasound Bone Healing System | $171 | 2 payments
|
| Orthofix Medical | Physio-Stim | $44 | 2 payments
|
2021: $1,744
| Sequoia Surgical | None | $1,238 | 3 payments
|
| Arthrex | None | $199 | 2 payments
|
| Stryker | Prophecy | $157 | 1 payment
|
| Smith+Nephew | Collagenase Santyl | $88 | 1 payment
|
| Organogenesis | Puraply Antimicrobial | $38 | 1 payment
|
| Electronic Waveform Lab | None | $16 | 1 payment
|
| Orthofix Medical | Physio-Stim | $7 | 1 payment
|
2020: $930
| Sequoia Surgical | None | $914 | 2 payments
|
| Integra LifeSciences | Bilayer Wound Matrix (Bwm) | $16 | 1 payment
|
2019: $5,398
| Arthrex | None | $3,372 | 11 payments
|
| Medical Device Business Services | VA-Lcp Plates & Screws | $720 | 6 payments
|
| Treace Medical Concepts | Lapiplasty System | $487 | 4 payments
|
| Sequoia Surgical | None | $473 | 1 payment
|
| Stryker | Mako | $144 | 1 payment
|
| Integra LifeSciences | Bilayer Wound Matrix (Bwm) | $136 | 1 payment
|
| Orthofix Medical | Trinity Elite | $67 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134486160
- Licence
- CA E5124
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2012-04-16
- NPI last updated
- 2015-07-13
This is when the NPI record was last certified, not a medical board exam.